ANXA2‐mediated Phagocytosis Generates AR + Macrophages to Confer Enzalutamide Resistance in Prostate Cancer
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Yong Luo, Tianlong Luo, Lingfeng Li, Qi Sun, Dongquan Li, Shanhe Huang, Zonglin Li, Weilong Lin, Yuan Ou, Tao Du, Shengmeng Peng, Kewei Xu, Bisheng Cheng, Hai Huang |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Cancer Cell‐Intrinsic Cholesterol Induces Lipid‐Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression
by: Shirong Peng, et al.
Published: (2026)
by: Shirong Peng, et al.
Published: (2026)
Developing a Novel Enzalutamide‐Resistant Prostate Cancer Model via AR F877L Mutation in LNCaP Cells
by: Ruifeng Wang, et al.
Published: (2024)
by: Ruifeng Wang, et al.
Published: (2024)
Enzalutamide Sensitizes Castration‐Resistant Prostate Cancer to Copper‐Mediated Cell Death
by: Xiang Gao, et al.
Published: (2024)
by: Xiang Gao, et al.
Published: (2024)
Real‐World Outcomes of Combination Therapy With Radium‐223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration‐Resistant Prostate Cancer
by: Kenichi Hata, et al.
Published: (2026)
by: Kenichi Hata, et al.
Published: (2026)
Myosteatosis Predicts Poor Prognosis in Patients With Castration‐Resistant Prostate Cancer Treated With Enzalutamide
by: Tomohiro Kanaki, et al.
Published: (2026)
by: Tomohiro Kanaki, et al.
Published: (2026)
Population Pharmacokinetics Analysis of Talazoparib and Enzalutamide Combination Therapy for Patients With Metastatic Castration‐Resistant Prostate Cancer
by: Mark Hadigol, et al.
Published: (2025)
by: Mark Hadigol, et al.
Published: (2025)
SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasis
by: Chen Tang, et al.
Published: (2025)
by: Chen Tang, et al.
Published: (2025)
Phase II Trial of Opaganib Addition in Metastatic Castration‐Resistant Prostate Cancer After Disease Progression on Abiraterone or Enzalutamide
by: Jacqueline T. Brown, et al.
Published: (2026)
by: Jacqueline T. Brown, et al.
Published: (2026)
RUNX1/SLAMF3 Axis Drives Immunosuppression to Contribute to Colorectal Cancer Liver Metastasis by Blocking Phagocytosis and Depleting C1QC + Tumor‐Associated Macrophages
by: Yinheng Luo, et al.
Published: (2025)
by: Yinheng Luo, et al.
Published: (2025)
Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First‐Line Treatment in Patients With Metastatic Castration‐Resistant Prostate Cancer: TALAPRO ‐2 Japanese Subgroup Analysis
by: Nobuaki Matsubara, et al.
Published: (2024)
by: Nobuaki Matsubara, et al.
Published: (2024)
Real‐World Overall Survival Comparison of Enzalutamide and Abiraterone In First‐ and Second‐Line Setting of Metastatic Castration‐Resistant Prostate Cancer
by: András Horváth, et al.
Published: (2025)
by: András Horváth, et al.
Published: (2025)
Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201 : Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration‐Resistant Prostate Cancer
by: Nadine Norton, et al.
Published: (2025)
by: Nadine Norton, et al.
Published: (2025)
Reactive Oxygen Species‐Mediated TRPM2 Activation Facilitates Phagocytosis of Macrophages to Reverse Profibrotic Phenotype
by: Shaoying Zhang, et al.
Published: (2025)
by: Shaoying Zhang, et al.
Published: (2025)
Effects of Phagocytosis of Cells Within Engineered Tissues on Macrophage Phenotype
by: Lindsay A. Steele, et al.
Published: (2025)
by: Lindsay A. Steele, et al.
Published: (2025)
Trimethylamine N‐Oxide Mitigates Perioperative Neurocognitive Disorders via ANXA1 Nuclear Translocation and M2 Microglial Polarization in the Hippocampus
by: Mengxin Que, et al.
Published: (2025)
by: Mengxin Que, et al.
Published: (2025)
Phase Separation of NFIB Suppresses SLC3A2‐Mediated Ferroptosis in Castration‐Resistant Prostate Cancer
by: Qiunuo Li, et al.
Published: (2026)
by: Qiunuo Li, et al.
Published: (2026)
Role of Macrophage Phagocytosis as Predictive Marker of the Prevalence of Coronary Heart Disease and Acute Coronary Syndromes
by: Yuming Wang, et al.
Published: (2025)
by: Yuming Wang, et al.
Published: (2025)
Antibody–Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions
by: Bisheng Cheng, et al.
Published: (2026)
by: Bisheng Cheng, et al.
Published: (2026)
A Hybrid Nanosystem for Prostate Cancer Therapy: Codelivery of Enzalutamide and Curcumin via Selenium‐Embedded Mesoporous Silica and Chitosan Nanoparticles
by: Zahra Tavakoli, et al.
Published: (2026)
by: Zahra Tavakoli, et al.
Published: (2026)
LMO7 Suppresses Tumor‐Associated Macrophage Phagocytosis of Tumor Cells Through Degradation of LRP1
by: Mengkai Li, et al.
Published: (2025)
by: Mengkai Li, et al.
Published: (2025)
Understanding Enzalutamide‐Resistance Based on a Functional Single‐Cell Approach
by: Changhui Xue, et al.
Published: (2025)
by: Changhui Xue, et al.
Published: (2025)
Aspergillus fumigatus Gliotoxin Inhibits LC3‐Associated Phagocytosis in Macrophages in a Calcium‐Dependent Manner
by: Yuqing Sun, et al.
Published: (2026)
by: Yuqing Sun, et al.
Published: (2026)
Provable Benefits of Sinusoidal Activation for Modular Addition
by: Huang, Tianlong, et al.
Published: (2025)
by: Huang, Tianlong, et al.
Published: (2025)
Phagocytosis of Primary Human Macrophages is Elevated by Ex Vivo Supplementation with n‐3 PUFA
by: Rebecca Kirchhoff, et al.
Published: (2026)
by: Rebecca Kirchhoff, et al.
Published: (2026)
PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer
by: Haixia He, et al.
Published: (2024)
by: Haixia He, et al.
Published: (2024)
Mechanism of Tumour‐Associated Macrophage‐Derived Exosomes in Chemo‐Sensitivity of Laryngeal Cancer by Regulating Aerobic Glycolysis via WTAP / GLUT ‐1
by: Xingmei Luo, et al.
Published: (2025)
by: Xingmei Luo, et al.
Published: (2025)
Long‐Term Follow‐Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial
by: Braden Millan, et al.
Published: (2025)
by: Braden Millan, et al.
Published: (2025)
PSMA‐Targeting Macrophage Membrane‐Coated Nanoparticles for Precision Diagnosis and Combination Therapy of Prostate Cancer
by: Keying Zhang, et al.
Published: (2026)
by: Keying Zhang, et al.
Published: (2026)
NINJ1 Facilitates Abdominal Aortic Aneurysm Formation via Blocking TLR4‐ANXA2 Interaction and Enhancing Macrophage Infiltration
by: Zhaoyu Wu, et al.
Published: (2024)
by: Zhaoyu Wu, et al.
Published: (2024)
The Pro‐Migratory and Pro‐Invasive Roles of Cancer‐Associated Fibroblasts Secreted IL‐17A in Prostate Cancer
by: Feng Gao, et al.
Published: (2025)
by: Feng Gao, et al.
Published: (2025)
Co‐Expression of MHC‐II and ANXA1: Mediators of PD‐1/PD‐L1 Therapy Resistance in Breast Cancer
by: Hao Wang, et al.
Published: (2025)
by: Hao Wang, et al.
Published: (2025)
Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec‐9 and Suppresses Macrophage Phagocytosis
by: Ying Wu, et al.
Published: (2025)
by: Ying Wu, et al.
Published: (2025)
Targeting Melatonin to Mitochondria Mitigates Castration‐Resistant Prostate Cancer by Inducing Pyroptosis
by: Xiaohui Chen, et al.
Published: (2025)
by: Xiaohui Chen, et al.
Published: (2025)
Macrophage plasticity: signaling pathways, tissue repair, and regeneration
by: Lingfeng Yan, et al.
Published: (2024)
by: Lingfeng Yan, et al.
Published: (2024)
Black goji berry anthocyanins extend lifespan and enhance the antioxidant defenses in Caenorhabditis elegans via the JNK‐1 and DAF‐16/FOXO pathways
by: Qiuxiong Xu, et al.
Published: (2024)
by: Qiuxiong Xu, et al.
Published: (2024)
POST: Photonic Swin Transformer for Automated and Efficient Prediction of PCSEL
by: Xin, Qi, et al.
Published: (2025)
by: Xin, Qi, et al.
Published: (2025)
Castration Resistance Accelerates Prostate Cancer Kinetics
by: Sheila Jonnatan, et al.
Published: (2026)
by: Sheila Jonnatan, et al.
Published: (2026)
Phosphorylation of IDH1 Facilitates Progestin Resistance in Endometrial Cancer
by: Jingjie Li, et al.
Published: (2024)
by: Jingjie Li, et al.
Published: (2024)
Proteomic Profiling of Alveolar Macrophages Identifies Loss of Lysosomal Content as an Indicator of Nanofiber‐Induced Frustrated Phagocytosis
by: Tobias Stobernack, et al.
Published: (2026)
by: Tobias Stobernack, et al.
Published: (2026)
Cracks Repairing and Resistance to Water Penetration Properties of Microbial Self‐Healing Cement
by: Luo Liu, et al.
Published: (2025)
by: Luo Liu, et al.
Published: (2025)
Similar Items
-
Cancer Cell‐Intrinsic Cholesterol Induces Lipid‐Associated Macrophage Differentiation via SP1 Palmitoylation to Promote Prostate Cancer Progression
by: Shirong Peng, et al.
Published: (2026) -
Developing a Novel Enzalutamide‐Resistant Prostate Cancer Model via AR F877L Mutation in LNCaP Cells
by: Ruifeng Wang, et al.
Published: (2024) -
Enzalutamide Sensitizes Castration‐Resistant Prostate Cancer to Copper‐Mediated Cell Death
by: Xiang Gao, et al.
Published: (2024) -
Real‐World Outcomes of Combination Therapy With Radium‐223 and Enzalutamide Compared With Enzalutamide Alone in Patients With Metastatic Castration‐Resistant Prostate Cancer
by: Kenichi Hata, et al.
Published: (2026) -
Myosteatosis Predicts Poor Prognosis in Patients With Castration‐Resistant Prostate Cancer Treated With Enzalutamide
by: Tomohiro Kanaki, et al.
Published: (2026)